MXCT
MaxCyte, Inc. · Healthcare
Director Stanley C Erck sold $192K of MaxCyte, Inc.
Sold$191,655
$4.02Price
47,689Shares
−15%Stake
What MXCT did after the filing
- The stock from Thu, Sep 5 close, $3.96
- −4.3%
- S&P 500, same days
- +6.3%
Measured over 30 trading days, to the Oct 17 close.
Traded Tue, Sep 3. Filed Thu, Sep 5, 1:10 PM ET, during the session. Returns use the Sep 5 close and the Oct 17 close. Not investment advice.